RMD Open 2021 Sep
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
Related Questions
Would you suggest switching to a viral vector vaccine, such as J&J?
New answer by at UT Southwestern (March 2, 2022)
I completely agree, the risk is probably low and I still advise my patients to be vaccinated.